How Senescent Macrophages Drive Aging and What We Can Do About It

Macrophages are among the immune system's most versatile cells, orchestrating infection defense, tissue repair, and the maintenance of organ homeostasis throughout life. Yet a growing body of research reveals that macrophages themselves are vulnerable to the aging process — accumulating damage and transitioning into a dysfunctional senescent state that may actively accelerate systemic aging.

This comprehensive review synthesizes current knowledge on macrophage senescence, detailing the molecular pathways that drive it. Key triggers include persistent DNA double-strand breaks, mitochondrial dysfunction and energy-sensing failure, epigenetic reprogramming that locks cells into pro-inflammatory states, and activation of the cGAS-STING innate immune sensing pathway. These signals converge to produce what researchers call immunosenescence — an impaired yet hyperinflammatory macrophage phenotype.

Senescent macrophages display a hallmark secretory profile known as the SASP (senescence-associated secretory phenotype), releasing cytokines and proteases that degrade surrounding tissue and recruit additional senescent cells in a self-reinforcing cycle. They also show impaired phagocytosis — meaning they can no longer efficiently clear dead cells, pathogens, or misfolded proteins — and aberrant polarization between pro- and anti-inflammatory states. The authors catalog how these features contribute to atherosclerotic plaque development, adipose tissue inflammation in metabolic disease, neuroinflammation in conditions like Alzheimer's disease, and tumor-promoting microenvironments in cancer.

However, senescent macrophages are not uniformly destructive. The review highlights context-dependent beneficial roles, including scar remodeling and resolution of acute inflammatory injury, suggesting that blanket elimination of senescent macrophages could be counterproductive in certain settings.

On the therapeutic side, the authors assess senolytics (drugs that selectively kill senescent cells), SASP-modulating compounds, and metabolic reprogramming strategies targeting mitochondrial function and NAD+ metabolism. These approaches hold real translational promise but face challenges including tissue specificity and the dual roles senescent macrophages play. This work frames macrophage senescence as a tractable target in the broader effort to extend human healthspan.